Totally no Tube (TNT) Uniportal Video-assisted Thoracoscopic Surgery (VATS) VS Traditional Uniportal VATS for Mediastinal Tumor
Mediastinal Tumor
About this trial
This is an interventional treatment trial for Mediastinal Tumor focused on measuring TNT (Totally no tube), uniportal VATS, mediastinal tumor
Eligibility Criteria
Inclusion Criteria:
The trial recruited patients aged from 18 to 75 years with a diagnosis of mediastinal tumor. Preoperative chest CT examination showed that shape of the mediastinal tumor was regular, boundary was clear, and maximum diameter of the mass was less than 4 cm. Other inclusion criteria included capability of giving consent and adequate organ function to tolerate uniportal thoracoscopy mediastinal tumor resection.
Exclusion Criteria:
Preoperative examination showed that the tumor invaded the surrounding blood vessels, pericardium, lung and other tissues or had distant metastasis; preoperative complications include severe coronary heart disease, arrhythmia and other serious cardiopulmonary diseases; large masses, difficult surgical procedures; manifestations of myasthenia gravis; hypovolemia, blood disorders, or abnormal clotting mechanism; pulmonary function and arterial blood gas analysis showed that patients could not tolerate surgery; previous thoracotomy; inability to obtain consent. Furthermore, the exclusion criteria were defifined as follows: intraoperative pleural adhesion or technical challenge to achieve hemostasis that make conversion from VATS to thoracotomy; clinician decides the patient should not continue the trial according to individual condition; patient withdraws from the trial.
Sites / Locations
- The Fourth Affiliated Hospital of China Medical University
Arms of the Study
Arm 1
Arm 2
Other
Other
TNT Uniportal Video-assisted Thoracoscopic Surgery
Uniportal Video-assisted Thoracoscopic Surgery
This group of patients underwent TNT uniportal VATS mediastinal tumor resection
This group of patients underwent traditional uniportal VATS mediastinal tumor resection